Overview

AXIM Biotechnologies is an innovative biotechnology company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products as well as alternative sources of energy. We prioritize the well-being of our customers while embracing a solid fiscal strategy. We believe to be setting the green standard for cannabinoid bioscience through the discovery and commercialization of new materials and technologies for healthy living, all while respecting the environment.

IR Nav

Company Profile

5 Rockefeller Plaza
20th Floor
New York, NY 10111

(212) 751-0001

Info@aximbiotech.com

Today

Intraday stock chart for AXIM

Leadership

Dr. George E. Anastassov

Chief Executive Officer

Dr. Philip. A. Van Damme

Chief Scientific/Medical Officer

Lekhram Changoer

Chief Technology Officer

View Management Team

Past Six Months

6 month stock chart for AXIM

Investor Relations

Grayling
101 Avenue of the Americas
8th Floor
New York, NY 10013
(646) 284 9474
shiwei.yin@grayling.com
lucia.domville@grayling.com

Transfer Agent

Action Stock Transfer Corporation
2469 E. Fort Union Blvd
Suite 214
Salt Lake City, UT 84121
(801) 274-1088
http://www.actionstocktransfer.com
info@actionstocktransfer.com

Justeene Blankenship
jb@actionstocktransfer.com

Auditors

RBSM LLP
805 Third Avenue
Suite 902
New York, NY 10022
(212) 868-3669
http://www.rbsmllp.com

Corporate Counsel

Phillip E. Koehnke, APC
PO Box 235472
Encinitas, CA 92024
(858) 229-8116
pek@peklaw.com

Subscribe to IR news and filing alerts

You can opt out at any time. We do not share or sell your info.